Anna Bauhofer

Long-term survival after allogeneic stem cell transplantation in patients with acute myeloid leukemia

Abstract Allogeneic hematopoietic cell transplantation (HCT) is the only curative treatment for patients with higher-risk acute myeloid leukemia (AML), but survival is limited by recurrent malignancy and complications such as organ toxicity and infections. This study evaluated ov...

Long-term follow-up of ruxolitinib pre-approval use in acute and chronic graft-versus-host disease

Abstract Steroid-refractory (SR) acute and chronic graft-versus-host disease (aGVHD/cGVHD) are frequent and serious complications after allogeneic hematopoietic stem cell transplantation. Ruxolitinib (RUX) is approved for the treatment of both conditions. Real world evidence may...